French drug trial details murky, should not influence future cannabinoid research
22-Jan-2016 -
Contrary to initial reports, the drug tested on paid volunteers in a French study, which resulted in one death and five hospitalizations, did not contain cannabis or cannabinoids. The drug, an FAAH inhibitor manufactured by the Portuguese company Bial, was instead designed to act upon the human ...
cannabinoids
clinical trials
drug-induced side effects